Joyce C. Niland

12.1k total citations · 3 hit papers
160 papers, 8.4k citations indexed

About

Joyce C. Niland is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Joyce C. Niland has authored 160 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Oncology, 39 papers in Cancer Research and 35 papers in Pathology and Forensic Medicine. Recurrent topics in Joyce C. Niland's work include Breast Cancer Treatment Studies (36 papers), Lymphoma Diagnosis and Treatment (22 papers) and Global Cancer Incidence and Screening (20 papers). Joyce C. Niland is often cited by papers focused on Breast Cancer Treatment Studies (36 papers), Lymphoma Diagnosis and Treatment (22 papers) and Global Cancer Incidence and Screening (20 papers). Joyce C. Niland collaborates with scholars based in United States, Canada and Austria. Joyce C. Niland's co-authors include Jane C. Weeks, Stephen B. Edge, Melissa E. Hughes, Richard L. Theriault, G. Schmidt, Rebecca A. Ottesen, Douglas W. Blayney, Yu‐Ning Wong, Eric P. Winer and Ann Vanderplas and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Joyce C. Niland

157 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

2013 609 citations Zheng Zhou, Alfred Rademaker et al. profile →
A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants

1991 485 citations G. Schmidt, Joyce C. Niland et al. profile →
Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network

2012 475 citations Nancy U. Lin, Ann Vanderplas et al. Cancer profile →

Peers

Countries citing papers authored by Joyce C. Niland

Since Specialization

Citations

This map shows the geographic impact of Joyce C. Niland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce C. Niland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce C. Niland more than expected).

Fields of papers citing papers by Joyce C. Niland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce C. Niland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce C. Niland. The network helps show where Joyce C. Niland may publish in the future.

Co-authorship network of co-authors of Joyce C. Niland

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce C. Niland. A scholar is included among the top collaborators of Joyce C. Niland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce C. Niland. Joyce C. Niland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinicopathologic and sociodemographic factors associated with late relapse triple negative breast cancer in a multivariable logistic model: A multi-institution cohort study 2023 ·The Breast ·(unknown), Carlos H. Bárcenas, Richard J. Bleicher, Adam L. Cohen, Sara H. Javid, Ellis Levine, Nancy U. Lin, Beverly Moy, Joyce C. Niland, Antonio C. Wolff, Michael J. Hassett, (unknown), Daniel G. Stover	0
2	Facilitating clinical research through automation: Combining optical character recognition with natural language processing 2022 ·Clinical Trials ·(unknown), (unknown), Rebecca A. Ottesen, Joyce C. Niland	9
3	Optimal Time to Ship Human Islets Post Tissue Culture to Maximize Islet Recovery 2020 ·Cell Transplantation ·Barbara Olack, Michael P. Alexander, C Swanson, (unknown), (unknown), (unknown), (unknown), (unknown), Keiko Omori, Peter J. Chlebeck, Laura J. Zitur, (unknown), Jonathan R. T. Lakey, Joyce C. Niland	6
4	Use of CA-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer 2016 ·Obstetrical & Gynecological Survey ·Katharine M. Esselen, Angel M. Cronin, Kristin Bixel, Michael A. Bookman, Robert A. Burger, David E. Cohn, Mihaela Cristea, Jennifer J. Griggs, Charles F. Levenback, Gina Mantia-Smaldone, Larissa A. Meyer, Ursula A. Matulonis, Joyce C. Niland, Charlotte C. Sun, David M. O’Malley, Alexi A. Wright	13
5	High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex 2016 ·Journal of the National Comprehensive Cancer Network ·Zheng Zhou, Alfred Rademaker, Leo I. Gordon, Ann S. LaCasce, Allison Crosby‐Thompson, Ann Vanderplas, Gregory A. Abel, Maria Alma Rodriguez, Auayporn Nademanee, Mark Kaminski, Myron S. Czuczman, Michael Millenson, Andrew D. Zelenetz, Joyce C. Niland, Jonathan W. Friedberg, Jane N. Winter	7
6	Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer 2015 ·Obstetrical & Gynecological Survey ·Alexi A. Wright, Angel M. Cronin, Dana Milne, Michael A. Bookman, Robert A. Burger, David E. Cohn, Mihaela Cristea, Jennifer J. Griggs, Nancy L. Keating, Charles F. Levenback, Gina Mantia-Smaldone, Ursula A. Matulonis, Larissa A. Meyer, Joyce C. Niland, Jane C. Weeks, David M. O’Malley	5
7	Comparison of referring and final pathology for patients with T‐cell lymphoma in the National Comprehensive Cancer Network 2014 ·Cancer ·Alex F. Herrera, Allison Crosby‐Thompson, Jonathan W. Friedberg, Gregory A. Abel, Myron S. Czuczman, Leo I. Gordon, Mark Kaminski, Michael Millenson, Auayporn Nademanee, Joyce C. Niland, Scott J. Rodig, Maria Alma Rodriguez, Andrew D. Zelenetz, Ann S. LaCasce	27
8	Effect of Adjuvant Chemotherapy on Survival of Patients With Stage III Colon Cancer Diagnosed After Age 75 Years 2012 ·Journal of Clinical Oncology ·Hanna K. Sanoff, William R. Carpenter, Til Stürmer‎, Richard M. Goldberg, Christopher F. Martin, Jason P. Fine, Nadine J. McCleary, Jeffrey A. Meyerhardt, Joyce C. Niland, Katherine L. Kahn, Maria J. Schymura, Deborah Schrag	181
9	Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study 2012 ·Breast Cancer Research ·Inês Vaz-Luís, Rebecca A. Ottesen, Melissa E. Hughes, P. Kelly Marcom, Beverly Moy, Hope S. Rugo, Richard L. Theriault, John L. Wilson, Joyce C. Niland, Jane C. Weeks, Nancy U. Lin	109
10	Comparative Effectiveness of Oxaliplatin vs Non–Oxaliplatin-containing Adjuvant Chemotherapy for Stage III Colon Cancer 2012 ·JNCI Journal of the National Cancer Institute ·Hanna K. Sanoff, William R. Carpenter, Christopher F. Martin, Daniel J. Sargent, Jeffrey A. Meyerhardt, Til Stürmer‎, Jason P. Fine, Jane C. Weeks, Joyce C. Niland, Katherine L. Kahn, Maria J. Schymura, Deborah Schrag	75
11	Continued Use of Trastuzumab Beyond Disease Progression in the National Comprehensive Cancer Network: Should We Practice Ahead of the Evidence? 2011 ·The Oncologist ·Yu‐Ning Wong, Rebecca A. Ottesen, Melissa E. Hughes, Joyce C. Niland, Richard L. Theriault, Stephen B. Edge, Douglas W. Blayney, Jane C. Weeks	7
12	An Informatics Blueprint for Healthcare Quality Information Systems 2006 ·Journal of the American Medical Informatics Association ·Joyce C. Niland, (unknown), Douglas C. Stahl	26
13	Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality 2002 ·Biology of Blood and Marrow Transplantation ·Ashwin Kashyap, John R. Wingard, Pablo J. Cagnoni, (unknown), (unknown), Wendy Hu, Karl G. Blume, Joyce C. Niland, Joycelynne Palmer, William P. Vaughan, Hugo F. Fernández, Richard Champlin, Stephen J. Forman, Börje S. Andersson	172
14	Myeloperoxidase Immunoreactivity in Adult Acute Lymphoblastic Leukemia 2001 ·American Journal of Clinical Pathology ·Daniel A. Arber, David S. Snyder, Miriam Fine, Andrew Dagis, Joyce C. Niland, Marilyn L. Slovak	29
15	Proof-of-Concept Process: Web Access to Research Protocols On-Line 1997 ·Europe PMC (PubMed Central) ·(unknown), (unknown), (unknown), Tamara Odom‐Maryon, Joyce C. Niland	1
16	A Survey of Biostatistical Consulting Units Throughout North America 1995 ·The American Statistician ·Joyce C. Niland, Tamara Odom‐Maryon, Jennifer Lee, Barbara C. Tilley	7
17	Herpes simplex Virus dna in normal corneas: Persistence without viral shedding from ganglia 1995 ·Journal of Medical Virology ·Harry Openshaw, James I. McNeill, (unknown), Joyce C. Niland, Edouard M. Cantin	59
18	Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. 1994 ·Journal of Clinical Oncology ·Margaret O’Donnell, G. Schmidt, Bernard Tegtmeier, (unknown), J. L. Fahey, James I. Ito, AP Nademanee, Joyce C. Niland, PM Parker, EP Smith	131
19	EXTENDED FOLLOW-UP IN 212 LONG-TERM ALLOGENEIC BONE MARROW TRANSPLANT SURVIVORS ISSUES OF QUALITY OF LIFE 1993 ·Transplantation ·G. Schmidt, Joyce C. Niland, Stephen J. Forman, (unknown), Andrew Dagis, Marcia Grant, Betty Ferrell, (unknown), (unknown), Nelson J. Chao, Karl G. Blume	78
20	Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening, The Transfusion Safety Study/NHLBI Donor Repository 1989 ·Transfusion ·Steven Kleinman, Joyce C. Niland, Stanley P. Azen, Eva A. Operskalski, L. H. Barbosa, Amoz I. Chernoff, Virginia M. Edwards, Bruce A. Lenes, G. June Marshall, George J. Nemo, Gary L. Norman, H. A. Perkins, Johanna Pindyck, Frances A. Pitlick, S Rasheed, K Shriver, Pearl Toy, Peter A. Tomasulo, Alan A. Waldman, J. W. Mosley, (unknown)	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact